IL2 and cancer: For instance, the significant increases of IFN-γ and IL-2 seen after FSS treatment could be beneficial because IFN-γ is known to induce apoptosis in cancer cells, and IL-2 is known to increase persistence of chimeric antigen receptor (CAR) T cells after reinfusion [30, 31].